AKAadil Kakajiwala

Aadil Kakajiwala

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aadil Kakajiwala has a total of 103 co-authors. Here are the top co-authors by number of shared publications:

  • Sandra Amaral

    Division of Nephrology, Department of Pediatrics, The Children's Hospital of Philadelphia, 34th Street and Civic Center Blvd, Philadelphia, PA, 19104, USA

    4 shared publications
  • April Lederman

    Division of Nephrology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA

    3 shared publications
  • Kevin E. Meyers

    The University of Pennsylvania

    3 shared publications
  • Susan L. Furth

    3 shared publications
  • Bernard S. Kaplan

    Division of Nephrology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA

    2 shared publications
  • Bruce R. Pawel

    Department of Pathology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA

    2 shared publications

Latest Publications

  • Open Access

    An epidemiological assessment of hemodialysis, continuous kidney replacement therapy, and peritoneal dialysis in pediatric acute kidney injury patients

    by Sanat Subhash, Ethan Kalina, Jacob Almeda, Arwa Nada, Aadil Kakajiwala, Rupesh Raina

    Acute Kidney Injury (AKI) is common among pediatric patients, affecting 10-35% of critically ill children and 34% of non-critically ill children [1]. Pediatric AKI is associated with higher risk of...

  • A Hierarchical End Point Analysis of the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE ROCK) Cohort

    by Dana Y Fuhrman, Katja M Gist, Ayse Akcan Arikan, Sean M Bagshaw, Andrew D Shaw, Matthieu Legrand, D'ARcy Duquette, Shina Menon, Nicholas J Ollberding, Indrani Sarkar, et al.

    Key Points: Early trial of liberation from continuous renal replacement therapy was associated with improved patient-important clinical outcomes in children with preserved urine output. Hierarchical composite end point analysis demonstrated greater intensive care unit and hospital-free days among patients who underwent a liberation trial. These findings supported early assessment of readiness for liberation using urine output to guide decision making for children receiving continuous renal replacement therapy. Background: Data to guide assessment of readiness for liberation from continuous renal replacement therapy (CRRT) in children are limited, and hierarchical composite end points have not been applied in this setting. We evaluated whether performing a trial of CRRT liberation among patients with preserved urine output is associated with improved outcomes using a hierarchical end point approach. Methods: We conducted a retrospective cohort study of patients aged≤25 years from the multicenter Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease registry. Patients with urine output >0.5 ml/kg per hour for≥24 hours within the first 5 days after CRRT initiation were included. The primary exposure was a trial of CRRT liberation by day 5. The primary outcome was a hierarchical composite of: ( 1 ) 90-day mortality, ( 2 ) 90-day KRT dependence, ( 3 ) intensive care unit-free days, and ( 4 ) hospital-free days. Inverse probability weighting was used to balance baseline characteristics, and outcomes were compared using a win ratio analysis. Results: Among 366 eligible patients, 192 (53%) underwent a liberation trial by day 5. These patients were older, had higher reference serum creatinine levels, and exhibited lower illness severity when compared with those who did not undergo a trial of liberation. In adjusted analyses, a liberation trial was associated with an improved hierarchical outcome (win ratio, 2.14 [95% confidence interval, 1.56 to 2.94], P < 0.001), driven primarily by greater intensive care unit- and hospital-free days. Conclusion: Among CRRT recipients with preserved urine output, a trial of liberation by day 5 was associated with improved outcomes, supporting the early assessment of liberation readiness in patients with a urine output >0.5 ml/kg per hour.


  • The use of near-infrared spectroscopy to measure kidney oxygenation in the neonatal intensive care unit

    by Aadil Kakajiwala, Nivedita Kamath, Saudamini Nesargi, Lisa Goto, Suma Bhat Hoffman, Brianna Michelle Liberio, Jennifer A. Rumpel, Mona Khattab, Arwa Nada, Christine Stoops, et al.

    Near-infrared spectroscopy (NIRS) is a relatively recent technology, first applied in clinical contexts in the early 1970s. Critically ill neonates in the intensive care unit face unique post-natal adaptations that can be challenging when compounded by clinical co-morbidities. Given the size and limited blood volume of these patients, there is a need for non-invasive monitoring methods that go beyond traditional vital signs and laboratory assessments. NIRS offers a potential approach for monitoring regional tissue oxygenation and perfusion of the kidney with a potential for early detection of acute kidney injury in high-risk neonates. However, its application is not without challenges, including inconsistent normative values, technological and technique-related limitations, and uncertainties about its clinical applicability. Despite these challenges, NIRS monitoring of kidney oxygenation shows promise for supporting kidney health and informing clinical care decisions. In this educational review, we aim to outline the basic principles of NIRS as it relates to kidney oxygenation, summarize the current literature on its use for monitoring and clinical decision-making, discuss its limitations and knowledge gaps, and propose investigative approaches with future research directions. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information


  • Open Access

    Machine Learning-Based Prediction Model for ICU Mortality After Continuous Renal Replacement Therapy Initiation in Children

    by Sameer Thadani, Tzu-Chun Wu, Danny T. Y. Wu, Aadil Kakajiwala, Danielle E. Soranno, Gerard Cortina, Rachana Srivastava, Katja M. Gist, Shina Menon, on behalf of the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Diseases (WE-ROCK) Collaborators

    BACKGROUND: Continuous renal replacement therapy (CRRT) is the favored renal replacement therapy in critically ill patients. Predicting clinical outcomes for CRRT patients is difficult due to population heterogeneity, varying clinical practices, and limited sample sizes. OBJECTIVE: We aimed to predict survival to ICUs and hospital discharge in children and young adults receiving CRRT using machine learning (ML) techniques. DERIVATION COHORT: Patients less than 25 years of age receiving CRRT for acute kidney injury and/or volume overload from 2015 to 2021 (80%). VALIDATION COHORT: Internal validation occurred in a testing group of patients from the dataset (20%). PREDICTION MODEL: Retrospective international multicenter study utilizing an 80/20 training and testing cohort split, and logistic regression with L2 regularization (LR), decision tree, random forest (RF), gradient boosting machine, and support vector machine with linear kernel to predict ICU and hospital survival. Model performance was determined by the area under the receiver operating characteristic curve (AUROC) and the area under the precision-recall curve (AUPRC) due to the imbalance in the dataset. RESULTS: Of the 933 patients included in this study, 538 (54%) were male with a median age of 8.97 years and interquartile range (1.81–15.0 yr). The ICU mortality was 35% and hospital mortality was 37%. The RF had the best performance for predicting ICU mortality (AUROC, 0.791 and AUPRC, 0.878) and LR for hospital mortality (AUROC, 0.777 and AUPRC, 0.859). The top two predictors of ICU survival were Pediatric Logistic Organ Dysfunction-2 score at CRRT initiation and admission diagnosis of respiratory failure. CONCLUSIONS: These are the first ML models to predict survival at ICU and hospital discharge in children and young adults receiving CRRT. RF outperformed other models for predicting ICU mortality. Future studies should expand the input variables, conduct a more sophisticated feature selection, and use deep learning algorithms to generate more precise models.


  • Open Access

    Bartonella henselae infection-mediated shunt nephritis

    by Jennifer Nhan, Shriprasad Deshpande, Craig Futterman, Dong Hyang Kwon, Aadil Kakajiwala

    Serum anti-neutrophil cytoplasmic antibody (ANCA) positivity with membranoproliferative pattern on renal biopsy can be due to ANCA-associated vasculitis as well as chronic indolent infections. We present the case of an adolescent boy with congenital heart disease and history of cardiac surgery who presented with severe acute kidney injury requiring hemodialysis. Renal biopsy showed membranoproliferative glomerulonephritis with full-house immunofluorescence pattern. Low serum complements, PR3 ANCA positivity and elevated Bartonella immunoglobulin titers suggested a diagnosis of infective endocarditis-associated glomerulonephritis. Cardiac shunt revision and antibiotic therapy lead to improvement in kidney function. Chronic infections lead to formation of immune complexes that may cause deposit within the renal parenchyma and induce production of ANCA. The distinction of ANCA-associated vasculitis and chronic infections causing acute kidney injury is important in determining therapeutic management. While rare in the pediatric population, we highlight the importance in considering indolent infections in patients with acute glomerulonephritis and ANCA positivity, especially with risk factors.


  • Pediatric Mineral and Bone Disorder of Chronic Kidney Disease and Cardiovascular Disease

    by Kirsten Kusumi, Robin Kremsdorf, Aadil Kakajiwala, John D. Mahan


  • Rare cause of xanthinuria: a pediatric case of molybdenum cofactor deficiency B

    by Edward Jin Lee, Raja Dandamudi, Jorge L. Granadillo, Dorothy Katherine Grange, Aadil Kakajiwala

    Molybdenum cofactor is essential for the activity of multiple enzymes including xanthine dehydrogenase. Molybdenum cofactor deficiencies are rare inborn errors of metabolism. Clinically, they present with intractable seizures, axial hypotonia, and hyperekplexia. They further develop cerebral atrophy, microcephaly, global developmental delay and ectopia lentis. We report a 5-year-old female with clinically, biochemically and genetically confirmed molybdenum cofactor deficiency type B due to compound heterozygous pathogenic variants in the molybdenum cofactor synthesis 2 gene found on whole exome sequencing. The xanthine stones were a key clue towards diagnosis. No mutation was detected in XDH gene. Implementation of a low-purine diet, urine alkalization and hydration lead to a near complete decrease in stone burden. The patient received pyridoxine supplementation with improvement in energy levels and attentiveness. Despite reports of high mortality at a young age, our patient was 9 years old at the time of this writing. Molybdenum cofactor deficiencies should be considered in neonates with early-onset seizures, hypotonia, and feeding difficulties. Screening with serum uric acid levels and empiric treatment may be considered while awaiting genetic results.


  • Open Access

    Serum Calcification Propensity in Children on Chronic Hemodialysis

    by Aadil Kakajiwala, Andreas Pasch, Rachel Rogers, Andrew Hoofnagle, Sherin Meloni, Susan L. Furth, Mary B. Leonard, Lawrence Copelovitch, Michelle R. Denburg


  • The light at the end of the tunnel: an unusual case of acute kidney injury in a pediatric patient: Answers

    by Miriam Steinberg, Joseph P Gaut, Stanley Paul Hmiel, Aadil Kakajiwala

    Monoclonal gammopathies are a rare diagnosis in pediatric patients. A 19-year-old female patient with past medical history of hypogammaglobulinemia and natural killer cell deficiency and stage III follicular lymphoma, in remission, presented with a right-sided pneumonia, noted to have acute kidney injury and proteinuria. Complement C3 and C4 levels were normal. Anti-double-stranded DNA antibodies, antinuclear antibodies, anti-extractable nuclear antigen antibodies, and antineutrophil cytoplasmic antibodies were negative. A renal biopsy showed numerous fractured tubular casts that were periodic acid-Schiff and silver-stain negative and fuchsinophilic on trichrome stain, with associated giant cells, tubulitis, acute tubular injury, and tubular rupture. The tubular casts had 3+ staining for lambda light chains and 0–1+ staining for kappa light chains. These findings were consistent with light chain cast nephropathy (LCCN). Serum free light chains, serum immunofixation, urine protein electrophoresis, and urine immunofixation studies supported the renal biopsy diagnosis of LCCN. A bone marrow biopsy showed normal trilineage hematopoiesis and also revealed an atypical B cell population detected by flow cytometry. Pathology specimens from lesions in the distal small bowel were characteristic of diffuse large B cell lymphoma (DLBCL). Chemoreduction therapy followed by chemotherapy was initiated for the DLBCL. Three months after initiation of chemotherapy, the patient’s creatinine has improved by > 50%. The likely cause of her LCCN was the new diagnosis of a DLBCL. Other risk factors include her history of hypogammaglobulinemia, natural killer (NK) cell deficiency, community-acquired pneumonia, and prior follicular lymphoma. Our patient may be the youngest reported case of LCCN. Treatment of LCCN is based on treating the underlying clonal plasma cell or B cell proliferation, typically with chemotherapy.